Edgardo Schapachnik

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi request reprint Virtual cardiac symposia: Worldwide, Internet-based, educational forums for cardiologists
    Arthur J Moss
    Heart Research Follow Up Program, Cardiology Unit of the Department of Medicine, University of Rochester School of Medicine, Rochester, New York, USA
    Am J Cardiol 94:1588-9. 2004
  2. ncbi request reprint Andersen syndrome: the newest variant of the hereditary-familial long QT syndrome
    Andrés Ricardo Pérez Riera
    ABC University Fundação Santo André, Sao Paulo, Brazil
    Ann Noninvasive Electrocardiol 9:175-9. 2004
  3. ncbi request reprint Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome
    Andrés Ricardo Pérez Riera
    ABC Faculty of Medicine, Foundation of ABC, Santo Andre, Brazil
    Cardiol J 15:209-19. 2008

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Virtual cardiac symposia: Worldwide, Internet-based, educational forums for cardiologists
    Arthur J Moss
    Heart Research Follow Up Program, Cardiology Unit of the Department of Medicine, University of Rochester School of Medicine, Rochester, New York, USA
    Am J Cardiol 94:1588-9. 2004
    ....
  2. ncbi request reprint Andersen syndrome: the newest variant of the hereditary-familial long QT syndrome
    Andrés Ricardo Pérez Riera
    ABC University Fundação Santo André, Sao Paulo, Brazil
    Ann Noninvasive Electrocardiol 9:175-9. 2004
    ..1, resulting in a loss or suppression of the function of this channel...
  3. ncbi request reprint Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome
    Andrés Ricardo Pérez Riera
    ABC Faculty of Medicine, Foundation of ABC, Santo Andre, Brazil
    Cardiol J 15:209-19. 2008
    ..Trecitilide, tedisamil, ersentilide, ambasilide, chromanol and sematilide are class III miscellaneous agents. Old mixed agents are sotalol and bretylium. The present article reviews the main trials accomplished with these drugs...